Centocor Seeks Continuing Damages Over Humira
The complaint — filed Dec. 28 in the U.S. District Court for the Eastern District of Texas — seeks actual and enhanced damages based on Abbott's alleged continuing willful infringement of Centocor's patent.
In June 2009, a jury in the same court awarded Centocor $1.17 billion in lost profits...
Already a subscriber? Click here to login